Joao Siffert M.D., SVP, R&D at AVANIR PHARMACEUTICALS, INC. (AVNR), sold 21,094 shares at $4.22 ($89K) on 2013-09-18, disclosed to the SEC on 2013-09-19.
Scheduled sale ($89k) by SVP, R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| AVNR | SELL | 2014-10-24 | $99K | — | Filing → |
| AVNR | SELL | 2014-05-30 | $70K | — | Filing → |
| AVNR | SELL | 2013-12-20 | $16K | — | Filing → |